Showing results (31-40 of 59) with videos related to
Sort By:
Pageof 6
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 1, 1983
Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometryD W Hedley, M L Friedlander, I W Taylor, et al.International Journal of Cancer|March 15, 1989
Amplification of c-ras-Ki oncogene in human ovarian tumoursE M Boltz, R F Kefford, J A Leary, et al.Cancer Chemotherapy and Pharmacology|January 1, 1989
A phase I study of trimetrexate (NSC 352122) administered by 5-day continuous intravenous infusionJ F Bishop, D Raghavan, I N Olver, et al.British Journal of Cancer|July 1, 1990
Demonstration of somatic rearrangements and genomic heterogeneity in human ovarian cancer by DNA fingerprintingE M Boltz, P Harnett, J Leary, et al.European Journal of Cancer & Clinical Oncology|May 1, 1983
The influence of age on the DNA ploidy levels of breast tumoursI W Taylor, E A Musgrove, M L Friedlander, et al.Family Process|August 7, 1998
Assessing individual family members' constructions of family problemsL Heatherington, M L Friedlander, B Johnson, et al.JAMA|November 8, 1985
Posttraumatic stress disorder from pentaborane intoxication. Neuropsychiatric evaluation and short-term follow-upJ J Silverman, R P Hart, L K Garrettson, et al.Cancer Research|January 1, 1984
Influence of cellular DNA content on survival in advanced ovarian cancerM L Friedlander, D W Hedley, I W Taylor, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1983
Ploidy as a prognostic factor in ovarian cancerM L Friedlander, I W Taylor, P Russell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Cisplatin-based chemotherapy for ovarian germ cell malignancies: the Australian experienceE Segelov, J Campbell, M Ng, et al.Pageof 6